ICD-10-PCS Code Range for Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

ICD-10-PCS Code Range for Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products is medical classification list by Centers for Medicare and Medicaid Services (CMS).

ICD-10-PCS code range (3E0), contains ICD-10-PCS codes for Circulatory, Administration, Physiological Systems and Anatomical Regions, Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

Image 1
PCS Tables

3E0

3 Administration
E Physiological Systems and Anatomical Regions
0 Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
Body System / Region Approach Substance Qualifier
Character 4 Character 5 Character 6 Character 7
Body System (Character 4)
0 Skin and Mucous Membranes
Approach (Character 5)
X External
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
0 Skin and Mucous Membranes
Approach (Character 5)
X External
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
0 Skin and Mucous Membranes
Approach (Character 5)
X External
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
B Anesthetic Agent
K Other Diagnostic Substance
M Pigment
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
0 Skin and Mucous Membranes
Approach (Character 5)
X External
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
0 Open
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
A Anti-Infective Envelope
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
A Anti-Infective Envelope
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
4 Serum, Toxoid and Vaccine
Qualifier (Character 7)
0 Influenza Vaccine
Z No Qualifier
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
J Other Hormone
Body System (Character 4)
2 Muscle
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
2 Muscle
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
2 Muscle
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
2 Muscle
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
4 Serum, Toxoid and Vaccine
Qualifier (Character 7)
0 Influenza Vaccine
Z No Qualifier
Body System (Character 4)
2 Muscle
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
5 Other Antineoplastic
M Monoclonal Antibody
P Clofarabine
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
F Intracirculatory Anesthetic
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
P Platelet Inhibitor
R Antiarrhythmic
T Destructive Agent
X Vasopressor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
N Blood Brain Barrier Disruption
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
U Pancreatic Islet Cells
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
H Human B-type Natriuretic Peptide
J Other Hormone
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
W Immunotherapeutic
Qualifier (Character 7)
K Immunostimulator
L Immunosuppressive
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
5 Other Antineoplastic
M Monoclonal Antibody
P Clofarabine
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
F Intracirculatory Anesthetic
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
P Platelet Inhibitor
R Antiarrhythmic
T Destructive Agent
X Vasopressor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
N Blood Brain Barrier Disruption
Q Glucarpidase
R Other Therapeutic Monoclonal Antibody
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
U Pancreatic Islet Cells
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
H Human B-type Natriuretic Peptide
J Other Hormone
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
W Immunotherapeutic
Qualifier (Character 7)
K Immunostimulator
L Immunosuppressive
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
5 Other Antineoplastic
M Monoclonal Antibody
P Clofarabine
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
F Intracirculatory Anesthetic
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
P Platelet Inhibitor
R Antiarrhythmic
T Destructive Agent
X Vasopressor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
N Blood Brain Barrier Disruption
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
H Human B-type Natriuretic Peptide
J Other Hormone
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
W Immunotherapeutic
Qualifier (Character 7)
K Immunostimulator
L Immunosuppressive
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
5 Other Antineoplastic
M Monoclonal Antibody
P Clofarabine
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
F Intracirculatory Anesthetic
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
P Platelet Inhibitor
R Antiarrhythmic
T Destructive Agent
X Vasopressor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
N Blood Brain Barrier Disruption
Q Glucarpidase
R Other Therapeutic Monoclonal Antibody
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
H Human B-type Natriuretic Peptide
J Other Hormone
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
W Immunotherapeutic
Qualifier (Character 7)
K Immunostimulator
L Immunosuppressive
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
5 Other Antineoplastic
M Monoclonal Antibody
P Clofarabine
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
F Intracirculatory Anesthetic
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
P Platelet Inhibitor
R Antiarrhythmic
T Destructive Agent
X Vasopressor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
N Blood Brain Barrier Disruption
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
H Human B-type Natriuretic Peptide
J Other Hormone
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
W Immunotherapeutic
Qualifier (Character 7)
K Immunostimulator
L Immunosuppressive
Body System (Character 4)
7 Coronary Artery
8 Heart
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
7 Coronary Artery
8 Heart
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
7 Coronary Artery
8 Heart
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
K Other Diagnostic Substance
P Platelet Inhibitor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
7 Coronary Artery
8 Heart
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
9 Nose
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
9 Nose
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
9 Nose
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
9 Nose
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
A Bone Marrow
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
A Bone Marrow
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
B Ear
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
B Ear
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
B Ear
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
3 Anti-inflammatory
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
B Ear
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
C Eye
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
C Eye
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
C Eye
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
3 Anti-inflammatory
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
M Pigment
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
C Eye
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
C Eye
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
D Mouth and Pharynx
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
D Mouth and Pharynx
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
D Mouth and Pharynx
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
R Antiarrhythmic
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
D Mouth and Pharynx
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
S Gas
Qualifier (Character 7)
D Nitric Oxide
F Other Gas
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
U Pancreatic Islet Cells
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
0 Open
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
7 Other Thrombolytic
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
5 Adhesion Barrier
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
0 Open
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Y Hyperthermic
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
5 Adhesion Barrier
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
0 Open
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
5 Adhesion Barrier
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
L Sperm
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
V Hormone
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
Q Fertilized Ovum
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
L Sperm
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
V Hormone
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
Q Fertilized Ovum
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
A Stem Cells, Embryonic
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
E Stem Cells, Somatic
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
0 Open
Substance (Character 6)
A Stem Cells, Embryonic
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
0 Open
Substance (Character 6)
E Stem Cells, Somatic
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
A Stem Cells, Embryonic
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
E Stem Cells, Somatic
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
S Epidural Space
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
S Epidural Space
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
S Epidural Space
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
S Epidural Space
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
S Epidural Space
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
S Epidural Space
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
T Peripheral Nerves and Plexi
X Cranial Nerves
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
B Anesthetic Agent
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
T Peripheral Nerves and Plexi
X Cranial Nerves
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
U Joints
Approach (Character 5)
0 Open
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
U Joints
Approach (Character 5)
0 Open
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
B Recombinant Bone Morphogenetic Protein
Body System (Character 4)
U Joints
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
U Joints
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
U Joints
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
U Joints
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
B Recombinant Bone Morphogenetic Protein
C Other Substance
Body System (Character 4)
U Joints
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
U Joints
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
V Bones
Approach (Character 5)
0 Open
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
B Recombinant Bone Morphogenetic Protein
C Other Substance
Body System (Character 4)
V Bones
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
V Bones
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
V Bones
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
V Bones
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
B Recombinant Bone Morphogenetic Protein
C Other Substance
Body System (Character 4)
V Bones
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
W Lymphatics
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
W Lymphatics
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
W Lymphatics
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
W Lymphatics
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas

January 01, 1970
Novitas and FCSO will require documentation for certain pathology and laboratory claims. Medicare Administrative Contractors MAC Novitas Solutions and First Coast Service Options FCSO recently announc... [ Read More ]
January 01, 1970
Potential erroneous Medicare payments million to treat patients with opioid use disorder OUD are estimated at 17.8 million. The opioid crisis in the United States has led to record numbers of people d... [ Read More ]
January 01, 1970
Get an overview of key updates to the postacute care quality reporting programs for 2025. The Centers for Medicare 38 Medicaid Services is offering a crosssetting webbased training course that provide... [ Read More ]
January 01, 1970
Hospitals should use this tool to protect their profit margins. Diagnosisrelated group DRG validation ensures the accuracy of DRG assignment and payment for inpatient hospital stays. Since inpatient c... [ Read More ]
January 01, 1970
Meet a member who has made an indelible impression in the healthcare industry. AAPCs Member of the Month Nancy Reading RN BS CPC CPCP CPCI is a longtime member and a pillar in the healthcare community... [ Read More ]